Clinical Trial Update: Examining the Effect of Different Diuretics on Fluid Retention in Diabetics Treated With Rosiglitazone. [Phase 4]

View source ↗

Summary

This Phase 4 trial evaluated whether different diuretics influence fluid retention in patients with diabetes who are treated with rosiglitazone.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Rosiglitazone (rosiglitazone)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Diabetes Mellitus | Phase 4 | Status: COMPLETED